ResMed has updated its AirMini product, which also happens to be the world’s smallest PAP (Positive Airway Pressure) device, so that it can connect to remote patient monitoring platform AirView.

The connectivity between AirMini and AirView enables clinicians to see patients’ nightly data, verify adherence, and spot therapy issues. This in turn should provide clinicians with an opportunity to educate and engage patients to reach the best possible health outcomes.

Monitoring is said to be a key factor in keeping patients healthy through regular therapy use, with a recent study showing that more than 87 percent of patients were adherent when remote and self-monitoring tools were used.

“AirMini and AirView are the perfect pair for traveling with CPAP and APAP therapy,” ResMed CEO Mick Farrell said in a statement. “ResMed has combined self- and remote monitoring and waterless humidification to put a world-class, world-traveling therapy experience literally in the palm of your hand.”

To enable the new functionality, patients will have to download or update the latest AirMini by ResMed 1.2 app, and opt-in to upload data to the cloud. Then, home medical equipment (HME) providers can view the same reports, charts, notes and therapy thresholds in AirView like they can for ResMed’s bedside Air10 devices, helping them monitor more patients in less time. HMEs can register their patients’ AirMini devices through AirView, Brightree or U-Sleep patient management platforms just as they would a ResMed Air10 bedside device.

AirMini is available in 15 countries across North America, Europe and Asia-Pacific, with more countries to follow.